Publications by authors named "Cristian Mendez-Sepulveda"
P R Health Sci J
September 2017
Article Synopsis
- The objective of the study was to compare the cost-effectiveness of pharmacogenetic-guided dosing of warfarin versus the standard dosing method using a Markov model.
- The analysis found that the pharmacogenetic strategy led to a slight increase in quality-adjusted life years (QALYs) but resulted in higher costs, resulting in an incremental cost-utility ratio (ICUR) indicating it was not cost-effective.
- The conclusion drawn suggests that pharmacogenetic-guided dosing for warfarin does not offer a superior cost-utility benefit compared to standard dosing practices.
